Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
14-day dose-ranging trial of indacaterol Twisthaler in persistent asthma
2007-003191-19Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of indacaterol in persistent asthma (6 arms), sponsored by Novartis. Primary endpoint: Trough FEV1 after 14 days. Started Aug 2007; status: completed.
02
Drugs
indacaterol
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2007-003191-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003191-19.